Archive

July 2026.

Field Notes

Industry roundups

The FDA Would Credential Generative AI Like a Clinician. You Still Answer for a Model You Don’t Own. Microbot’s FDA-Cleared Robot Now Meets the Hospital’s Value Analysis Committee Earlier The Navy Put a Startup’s Hypersonic Missile Into Production. Its Investors Paid for the Development First. Robotaxis Proved the Driving. How to Count the Service Work Every Demo Leaves Out The FDA’s Draft Surgical Robot Guidance Lets the Hardest Procedure Cover the Rest The FDA Panel Said Yes to Grail’s Cancer Test. It Said No to the Word Early. CATL’s Licensee Pays for the Factory. CATL Plans to Sell It the Cells. GM Shipped Patriot Interceptor Parts in 22 Days. Lockheed Is Buying the Rate. FDA Approved the First Sirolimus Balloon. A Subgroup Decides Who Buys It. Your FDA Clearance Covers One Configuration. Your Roadmap Is the Queue. A Humanoid Holds Twice the Rare Earth of an EV. Getting It Back Was Decided at the Design Review. Olympus Backed This Endoscopy Robot, Then Took an Option on Its Rival ISO 21423 Isn’t Published Yet. The Code That Speaks It Is Already Free. A $400 Million Device Failed Its Trial. Its Engineers Bought It Back. The FDA Approved This Valve for Symptom-Free Patients. Medicare Started Paying Sixteen Months Later. When No Law Fits Your Product, Regulators Reach for the Nearest One J&J Bought Into a $37 Billion Orthopedics Market. It's Leaving a $50 Billion One. GM Is Building Battery Cells It Will Never Sell So It Can Judge the Ones It Buys Teradyne Is Suing Over Three Universal Robots Patents. All Three Expire in March. Axogen Paid $200 Million to Widen the Pool of Surgeons Who Can Repair a Nerve Nine Sites, $1.8 Million: How to Read a Hardware Company's Traction The Army Bought Its First Production Laser. The Factory Was Funded in March. Cellares' Machine Met Every Release Spec. Bristol Myers Squibb Still Walked Away. Stryker's Surgical Headset Is FDA Authorized. Its Own Label Keeps the Monitors On. Medtronic Paid $700 Million for a Surgical Robot It Can't Sell in the United States FDA Reclassified This Cancer Test Category. Fewer Than Five People Commented. Kardium's Cleanroom Builds 500 a Year. The Business Needs 30,000. Two in Ten Storage Projects Now Treat the 30% Tax Credit as Optional Boston Scientific Is Pulling Catheters Its Complaint Data Never Flagged
Back to archive